Celestica (CLS) PT Raised to $41 at Argus
Get Alerts CLS Hot Sheet
Price: $362.16 +1.58%
Rating Summary:
20 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 14 | New: 37
Rating Summary:
20 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 14 | New: 37
Join SI Premium – FREE
Argus analyst Kristina Ruggeri raised the price target on Celestica (NYSE: CLS) to $41.00 (from $26.00) while maintaining a Buy rating.
You May Also Be Interested In
- Teva Pharma (TEVA) PT Raised to $52 at Oppenheimer
- Zeta Global Holdings Corp (ZETA) PT Raised to $38 at KeyBanc
- Celestica to Hold Q3 2026 Financial Results and 2026 Investor and Analyst Day Conference Call
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share